Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Colloidal Gold Immunochromatography Products Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Colloidal Gold Immunochromatography Products Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-09-21
Pages: 179 Pages
Report ld: 5051874
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Colloidal Gold Immunochromatography Products Market Size(US$)
CAGR 2025-2031
3.4%
Market Size,2031
USD 3,058
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,501 million
Market Forecast in 2031(Value)
US$ 3,058 million
CAGR
3.4%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Colloidal Gold Immunochromatography Products market is projected to grow from US$ 2864 million in 2024 to US$ 3058 million by 2031, at a CAGR of 3.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
In 2024, global Colloidal Gold Immunochromatography Products sales reached approximately 2,562.66 M units, with an average global market price of around US$1,117 per K units.
Colloidal gold immunochromatography technology has developed rapidly in recent years and has been widely used in the biomedical field, particularly in medical testing. Colloidal gold immunochromatographic test strips primarily coat specific antigens or antibodies in the form of strips on the detection line of a NC membrane. The colloidal gold-labeled antigen or antibody is adsorbed onto a conjugate pad. When the sample is applied to the well at the end of the test strip, it migrates forward through capillary action, dissolving the colloidal gold-labeled antigen or antibody on the conjugate pad and then migrating to the detection line of the coated antigen or antibody. If the sample contains the corresponding antibody or antigen, the antigen or antibody coated on the detection line and the colloidal gold label bind to the corresponding antibody or antigen in the sample, forming an immune complex. The colloidal gold is concentrated at the detection line, forming a visible purple-red line. If the serum tested lacks the corresponding antibody, the colloidal gold label will not bind to the antigen or antibody coated on the detection line, resulting in no colloidal gold accumulation and no purple-red line appearing on the detection line. As the sample and colloidal gold marker continue to move upward to the control line, they bind to specific antibodies or antigens coated there, forming an immune complex and resulting in a purple-red line enriched with colloidal gold.
This detection technology offers advantages such as simplicity and speed, high specificity and sensitivity, single-sample measurement, intuitive results, and the absence of specialized equipment. It is suitable for grassroots units, hospitals, field workers, large-scale testing with tight deadlines, and large-scale surveys, and has enormous development potential and application prospects.
Market Development Opportunities & Main Driving Factors
Colloidal gold immunochromatography products have become increasingly popular as rapid and convenient diagnostic tools worldwide. The high prevalence of infectious diseases, particularly respiratory and gastrointestinal infections, has driven the demand for rapid diagnostic products. Additionally, the growing awareness of health and wellness among consumers has led to a higher acceptance of self-testing products, further expanding the market. Technological advancements, such as multiplex testing capabilities and the proliferation of portable devices, have broadened the application scenarios of these products in clinical, home, and environmental testing. Government emphasis on public health and supportive policies for rapid diagnostic technologies have also provided strong backing for market development.
Market Challenges, Risks, & Restraints
Despite the promising market outlook, colloidal gold immunochromatography products face several challenges and risks. Firstly, issues related to quality control and standardization need further attention, especially concerning product consistency across different regions and manufacturers. Secondly, the increasing number of homogeneous products in the market has intensified price competition, potentially impacting profit margins. Moreover, consumers' rising expectations for product accuracy and reliability require continuous investment in research and development to enhance product performance and meet market demands. Lastly, global supply chain instabilities, particularly concerning raw materials and production capacities, may affect market supply.
Downstream Demand Trends
Downstream demand is exhibiting diversification and personalization trends. The clinical diagnostics sector continues to require rapid and accurate testing products, especially in emergency and primary healthcare settings. The home self-testing market is also expanding rapidly, with consumers seeking convenient health monitoring solutions. Environmental monitoring and food safety sectors are increasing their demand for rapid testing technologies, driving the application of related products. With the widespread adoption of health management concepts, colloidal gold immunochromatography products are expected to extend beyond disease diagnosis to encompass health monitoring and disease prevention, further enriching market demand.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Colloidal Gold Immunochromatography Products market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Abbott
- Wondfo Biotech
- ALLTEST BIOTECH
- Orient Gene Biotech
- Innovita Biological
- Ihealth (Andon Health)
- Hotgen Biotech
- Hangzhou Biotest Biotech
- Assure Tech
- Lepu Medical
- Wantai Biological
- Bioperfectus
- Bioscience
- Getein Biotech
- YHLO Biotech
- BGI Genomics
- Easydiagnosis Biomedicine
- Vazyme Biotech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Drug and Drug Test Strips & Kits
- Infectious Disease Test Strips & Kits
- Cardiac Marker Test Strips & Kits
- Tumor Marker Detection Test Strips & Kits
- Others
Segment by Application
- Medical
- Domestic
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Colloidal Gold Immunochromatography Products study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Colloidal Gold Immunochromatography Products: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Colloidal Gold Immunochromatography Products Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Drug and Drug Test Strips & Kits
1.2.3 Infectious Disease Test Strips & Kits
1.2.4 Cardiac Marker Test Strips & Kits
1.2.5 Tumor Marker Detection Test Strips & Kits
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global Colloidal Gold Immunochromatography Products Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medical
1.3.3 Domestic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Colloidal Gold Immunochromatography Products Revenue Estimates and Forecasts 2020-2031
2.2 Global Colloidal Gold Immunochromatography Products Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Colloidal Gold Immunochromatography Products Sales Estimates and Forecasts 2020-2031
2.4 Global Colloidal Gold Immunochromatography Products Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Colloidal Gold Immunochromatography Products Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Colloidal Gold Immunochromatography Products Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Drug and Drug Test Strips & Kits Market Size by Manufacturers
3.5.2 Infectious Disease Test Strips & Kits Market Size by Manufacturers
3.5.3 Cardiac Marker Test Strips & Kits Market Size by Manufacturers
3.5.4 Tumor Marker Detection Test Strips & Kits Market Size by Manufacturers
3.5.5 Others Market Size by Manufacturers
3.6 Global Colloidal Gold Immunochromatography Products Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Colloidal Gold Immunochromatography Products Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Colloidal Gold Immunochromatography Products Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Colloidal Gold Immunochromatography Products Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Colloidal Gold Immunochromatography Products Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Colloidal Gold Immunochromatography Products Sales and Revenue by Type (2020-2031)
6.4 North America Colloidal Gold Immunochromatography Products Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Colloidal Gold Immunochromatography Products Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Colloidal Gold Immunochromatography Products Sales and Revenue by Type (2020-2031)
7.4 Europe Colloidal Gold Immunochromatography Products Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Colloidal Gold Immunochromatography Products Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Colloidal Gold Immunochromatography Products Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Colloidal Gold Immunochromatography Products Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Colloidal Gold Immunochromatography Products Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Colloidal Gold Immunochromatography Products Sales and Revenue by Type (2020-2031)
9.4 Central and South America Colloidal Gold Immunochromatography Products Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Colloidal Gold Immunochromatography Products Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Colloidal Gold Immunochromatography Products Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Colloidal Gold Immunochromatography Products Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Colloidal Gold Immunochromatography Products Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.1.4 Abbott Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Colloidal Gold Immunochromatography Products Sales by Product in 2024
11.1.6 Abbott Colloidal Gold Immunochromatography Products Sales by Application in 2024
11.1.7 Abbott Colloidal Gold Immunochromatography Products Sales by Geographic Area in 2024
11.1.8 Abbott Colloidal Gold Immunochromatography Products SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Wondfo Biotech
11.2.1 Wondfo Biotech Corporation Information
11.2.2 Wondfo Biotech Business Overview
11.2.3 Wondfo Biotech Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.2.4 Wondfo Biotech Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Wondfo Biotech Colloidal Gold Immunochromatography Products Sales by Product in 2024
11.2.6 Wondfo Biotech Colloidal Gold Immunochromatography Products Sales by Application in 2024
11.2.7 Wondfo Biotech Colloidal Gold Immunochromatography Products Sales by Geographic Area in 2024
11.2.8 Wondfo Biotech Colloidal Gold Immunochromatography Products SWOT Analysis
11.2.9 Wondfo Biotech Recent Developments
11.3 ALLTEST BIOTECH
11.3.1 ALLTEST BIOTECH Corporation Information
11.3.2 ALLTEST BIOTECH Business Overview
11.3.3 ALLTEST BIOTECH Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.3.4 ALLTEST BIOTECH Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 ALLTEST BIOTECH Colloidal Gold Immunochromatography Products Sales by Product in 2024
11.3.6 ALLTEST BIOTECH Colloidal Gold Immunochromatography Products Sales by Application in 2024
11.3.7 ALLTEST BIOTECH Colloidal Gold Immunochromatography Products Sales by Geographic Area in 2024
11.3.8 ALLTEST BIOTECH Colloidal Gold Immunochromatography Products SWOT Analysis
11.3.9 ALLTEST BIOTECH Recent Developments
11.4 Orient Gene Biotech
11.4.1 Orient Gene Biotech Corporation Information
11.4.2 Orient Gene Biotech Business Overview
11.4.3 Orient Gene Biotech Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.4.4 Orient Gene Biotech Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Orient Gene Biotech Colloidal Gold Immunochromatography Products Sales by Product in 2024
11.4.6 Orient Gene Biotech Colloidal Gold Immunochromatography Products Sales by Application in 2024
11.4.7 Orient Gene Biotech Colloidal Gold Immunochromatography Products Sales by Geographic Area in 2024
11.4.8 Orient Gene Biotech Colloidal Gold Immunochromatography Products SWOT Analysis
11.4.9 Orient Gene Biotech Recent Developments
11.5 Innovita Biological
11.5.1 Innovita Biological Corporation Information
11.5.2 Innovita Biological Business Overview
11.5.3 Innovita Biological Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.5.4 Innovita Biological Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Innovita Biological Colloidal Gold Immunochromatography Products Sales by Product in 2024
11.5.6 Innovita Biological Colloidal Gold Immunochromatography Products Sales by Application in 2024
11.5.7 Innovita Biological Colloidal Gold Immunochromatography Products Sales by Geographic Area in 2024
11.5.8 Innovita Biological Colloidal Gold Immunochromatography Products SWOT Analysis
11.5.9 Innovita Biological Recent Developments
11.6 Ihealth (Andon Health)
11.6.1 Ihealth (Andon Health) Corporation Information
11.6.2 Ihealth (Andon Health) Business Overview
11.6.3 Ihealth (Andon Health) Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.6.4 Ihealth (Andon Health) Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Ihealth (Andon Health) Recent Developments
11.7 Hotgen Biotech
11.7.1 Hotgen Biotech Corporation Information
11.7.2 Hotgen Biotech Business Overview
11.7.3 Hotgen Biotech Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.7.4 Hotgen Biotech Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Hotgen Biotech Recent Developments
11.8 Hangzhou Biotest Biotech
11.8.1 Hangzhou Biotest Biotech Corporation Information
11.8.2 Hangzhou Biotest Biotech Business Overview
11.8.3 Hangzhou Biotest Biotech Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.8.4 Hangzhou Biotest Biotech Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Hangzhou Biotest Biotech Recent Developments
11.9 Assure Tech
11.9.1 Assure Tech Corporation Information
11.9.2 Assure Tech Business Overview
11.9.3 Assure Tech Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.9.4 Assure Tech Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Assure Tech Recent Developments
11.10 Lepu Medical
11.10.1 Lepu Medical Corporation Information
11.10.2 Lepu Medical Business Overview
11.10.3 Lepu Medical Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.10.4 Lepu Medical Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Lepu Medical Recent Developments
11.11 Wantai Biological
11.11.1 Wantai Biological Corporation Information
11.11.2 Wantai Biological Business Overview
11.11.3 Wantai Biological Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.11.4 Wantai Biological Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Wantai Biological Recent Developments
11.12 Bioperfectus
11.12.1 Bioperfectus Corporation Information
11.12.2 Bioperfectus Business Overview
11.12.3 Bioperfectus Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.12.4 Bioperfectus Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Bioperfectus Recent Developments
11.13 Bioscience
11.13.1 Bioscience Corporation Information
11.13.2 Bioscience Business Overview
11.13.3 Bioscience Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.13.4 Bioscience Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Bioscience Recent Developments
11.14 Getein Biotech
11.14.1 Getein Biotech Corporation Information
11.14.2 Getein Biotech Business Overview
11.14.3 Getein Biotech Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.14.4 Getein Biotech Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Getein Biotech Recent Developments
11.15 YHLO Biotech
11.15.1 YHLO Biotech Corporation Information
11.15.2 YHLO Biotech Business Overview
11.15.3 YHLO Biotech Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.15.4 YHLO Biotech Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 YHLO Biotech Recent Developments
11.16 BGI Genomics
11.16.1 BGI Genomics Corporation Information
11.16.2 BGI Genomics Business Overview
11.16.3 BGI Genomics Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.16.4 BGI Genomics Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 BGI Genomics Recent Developments
11.17 Easydiagnosis Biomedicine
11.17.1 Easydiagnosis Biomedicine Corporation Information
11.17.2 Easydiagnosis Biomedicine Business Overview
11.17.3 Easydiagnosis Biomedicine Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.17.4 Easydiagnosis Biomedicine Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Easydiagnosis Biomedicine Recent Developments
11.18 Vazyme Biotech
11.18.1 Vazyme Biotech Corporation Information
11.18.2 Vazyme Biotech Business Overview
11.18.3 Vazyme Biotech Colloidal Gold Immunochromatography Products Product Models, Descriptions and Specifications
11.18.4 Vazyme Biotech Colloidal Gold Immunochromatography Products Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Vazyme Biotech Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Colloidal Gold Immunochromatography Products Industry Chain
12.2 Colloidal Gold Immunochromatography Products Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Colloidal Gold Immunochromatography Products Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Colloidal Gold Immunochromatography Products Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Colloidal Gold Immunochromatography Products Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Colloidal Gold Immunochromatography Products Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Colloidal Gold Immunochromatography Products Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Colloidal Gold Immunochromatography Products Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Colloidal Gold Immunochromatography Products Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Colloidal Gold Immunochromatography Products Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Colloidal Gold Immunochromatography Products Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Colloidal Gold Immunochromatography Products Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (M Units)
Table 7. Global Colloidal Gold Immunochromatography Products Sales by Region (2020-2025) & (M Units)
Table 8. Global Colloidal Gold Immunochromatography Products Sales by Region (2026-2031) & (M Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Colloidal Gold Immunochromatography Products Sales by Manufacturers (2020-2025) & (M Units)
Table 11. Global Colloidal Gold Immunochromatography Products Sales Share by Manufacturers (2020-2025)
Table 12. Global Colloidal Gold Immunochromatography Products Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Colloidal Gold Immunochromatography Products Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Colloidal Gold Immunochromatography Products by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colloidal Gold Immunochromatography Products as of 2024)
Table 16. Global Colloidal Gold Immunochromatography Products Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Colloidal Gold Immunochromatography Products Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/K Units)
Table 18. Key Manufacturers Colloidal Gold Immunochromatography Products Manufacturing Base and Headquarters
Table 19. Global Colloidal Gold Immunochromatography Products Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Colloidal Gold Immunochromatography Products Sales by Type (2020-2025) & (M Units)
Table 23. Global Colloidal Gold Immunochromatography Products Sales by Type (2026-2031) & (M Units)
Table 24. Global Colloidal Gold Immunochromatography Products Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Colloidal Gold Immunochromatography Products Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Colloidal Gold Immunochromatography Products ASP by Type (2020-2031) & (US$/K Units)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Colloidal Gold Immunochromatography Products Sales by Application (2020-2025) & (M Units)
Table 29. Global Colloidal Gold Immunochromatography Products Sales by Application (2026-2031) & (M Units)
Table 30. Colloidal Gold Immunochromatography Products High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Colloidal Gold Immunochromatography Products Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Colloidal Gold Immunochromatography Products Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Colloidal Gold Immunochromatography Products ASP by Application (2020-2031) & (US$/K Units)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Colloidal Gold Immunochromatography Products Growth Accelerators and Market Barriers
Table 37. North America Colloidal Gold Immunochromatography Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Colloidal Gold Immunochromatography Products Sales (M Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Colloidal Gold Immunochromatography Products Growth Accelerators and Market Barriers
Table 40. Europe Colloidal Gold Immunochromatography Products Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Colloidal Gold Immunochromatography Products Sales (M Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Colloidal Gold Immunochromatography Products Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Colloidal Gold Immunochromatography Products Sales (M Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Colloidal Gold Immunochromatography Products Growth Accelerators and Market Barriers
Table 45. Southeast Asia Colloidal Gold Immunochromatography Products Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Colloidal Gold Immunochromatography Products Investment Opportunities and Key Challenges
Table 47. Central and South America Colloidal Gold Immunochromatography Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Colloidal Gold Immunochromatography Products Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Colloidal Gold Immunochromatography Products Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Abbott Corporation Information
Table 51. Abbott Description and Major Businesses
Table 52. Abbott Product Models, Descriptions and Specifications
Table 53. Abbott Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 54. Abbott Sales Value Proportion by Product in 2024
Table 55. Abbott Sales Value Proportion by Application in 2024
Table 56. Abbott Sales Value Proportion by Geographic Area in 2024
Table 57. Abbott Colloidal Gold Immunochromatography Products SWOT Analysis
Table 58. Abbott Recent Developments
Table 59. Wondfo Biotech Corporation Information
Table 60. Wondfo Biotech Description and Major Businesses
Table 61. Wondfo Biotech Product Models, Descriptions and Specifications
Table 62. Wondfo Biotech Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 63. Wondfo Biotech Sales Value Proportion by Product in 2024
Table 64. Wondfo Biotech Sales Value Proportion by Application in 2024
Table 65. Wondfo Biotech Sales Value Proportion by Geographic Area in 2024
Table 66. Wondfo Biotech Colloidal Gold Immunochromatography Products SWOT Analysis
Table 67. Wondfo Biotech Recent Developments
Table 68. ALLTEST BIOTECH Corporation Information
Table 69. ALLTEST BIOTECH Description and Major Businesses
Table 70. ALLTEST BIOTECH Product Models, Descriptions and Specifications
Table 71. ALLTEST BIOTECH Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 72. ALLTEST BIOTECH Sales Value Proportion by Product in 2024
Table 73. ALLTEST BIOTECH Sales Value Proportion by Application in 2024
Table 74. ALLTEST BIOTECH Sales Value Proportion by Geographic Area in 2024
Table 75. ALLTEST BIOTECH Colloidal Gold Immunochromatography Products SWOT Analysis
Table 76. ALLTEST BIOTECH Recent Developments
Table 77. Orient Gene Biotech Corporation Information
Table 78. Orient Gene Biotech Description and Major Businesses
Table 79. Orient Gene Biotech Product Models, Descriptions and Specifications
Table 80. Orient Gene Biotech Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 81. Orient Gene Biotech Sales Value Proportion by Product in 2024
Table 82. Orient Gene Biotech Sales Value Proportion by Application in 2024
Table 83. Orient Gene Biotech Sales Value Proportion by Geographic Area in 2024
Table 84. Orient Gene Biotech Colloidal Gold Immunochromatography Products SWOT Analysis
Table 85. Orient Gene Biotech Recent Developments
Table 86. Innovita Biological Corporation Information
Table 87. Innovita Biological Description and Major Businesses
Table 88. Innovita Biological Product Models, Descriptions and Specifications
Table 89. Innovita Biological Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 90. Innovita Biological Sales Value Proportion by Product in 2024
Table 91. Innovita Biological Sales Value Proportion by Application in 2024
Table 92. Innovita Biological Sales Value Proportion by Geographic Area in 2024
Table 93. Innovita Biological Colloidal Gold Immunochromatography Products SWOT Analysis
Table 94. Innovita Biological Recent Developments
Table 95. Ihealth (Andon Health) Corporation Information
Table 96. Ihealth (Andon Health) Description and Major Businesses
Table 97. Ihealth (Andon Health) Product Models, Descriptions and Specifications
Table 98. Ihealth (Andon Health) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 99. Ihealth (Andon Health) Recent Developments
Table 100. Hotgen Biotech Corporation Information
Table 101. Hotgen Biotech Description and Major Businesses
Table 102. Hotgen Biotech Product Models, Descriptions and Specifications
Table 103. Hotgen Biotech Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 104. Hotgen Biotech Recent Developments
Table 105. Hangzhou Biotest Biotech Corporation Information
Table 106. Hangzhou Biotest Biotech Description and Major Businesses
Table 107. Hangzhou Biotest Biotech Product Models, Descriptions and Specifications
Table 108. Hangzhou Biotest Biotech Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 109. Hangzhou Biotest Biotech Recent Developments
Table 110. Assure Tech Corporation Information
Table 111. Assure Tech Description and Major Businesses
Table 112. Assure Tech Product Models, Descriptions and Specifications
Table 113. Assure Tech Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 114. Assure Tech Recent Developments
Table 115. Lepu Medical Corporation Information
Table 116. Lepu Medical Description and Major Businesses
Table 117. Lepu Medical Product Models, Descriptions and Specifications
Table 118. Lepu Medical Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 119. Lepu Medical Recent Developments
Table 120. Wantai Biological Corporation Information
Table 121. Wantai Biological Description and Major Businesses
Table 122. Wantai Biological Product Models, Descriptions and Specifications
Table 123. Wantai Biological Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 124. Wantai Biological Recent Developments
Table 125. Bioperfectus Corporation Information
Table 126. Bioperfectus Description and Major Businesses
Table 127. Bioperfectus Product Models, Descriptions and Specifications
Table 128. Bioperfectus Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 129. Bioperfectus Recent Developments
Table 130. Bioscience Corporation Information
Table 131. Bioscience Description and Major Businesses
Table 132. Bioscience Product Models, Descriptions and Specifications
Table 133. Bioscience Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 134. Bioscience Recent Developments
Table 135. Getein Biotech Corporation Information
Table 136. Getein Biotech Description and Major Businesses
Table 137. Getein Biotech Product Models, Descriptions and Specifications
Table 138. Getein Biotech Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 139. Getein Biotech Recent Developments
Table 140. YHLO Biotech Corporation Information
Table 141. YHLO Biotech Description and Major Businesses
Table 142. YHLO Biotech Product Models, Descriptions and Specifications
Table 143. YHLO Biotech Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 144. YHLO Biotech Recent Developments
Table 145. BGI Genomics Corporation Information
Table 146. BGI Genomics Description and Major Businesses
Table 147. BGI Genomics Product Models, Descriptions and Specifications
Table 148. BGI Genomics Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 149. BGI Genomics Recent Developments
Table 150. Easydiagnosis Biomedicine Corporation Information
Table 151. Easydiagnosis Biomedicine Description and Major Businesses
Table 152. Easydiagnosis Biomedicine Product Models, Descriptions and Specifications
Table 153. Easydiagnosis Biomedicine Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 154. Easydiagnosis Biomedicine Recent Developments
Table 155. Vazyme Biotech Corporation Information
Table 156. Vazyme Biotech Description and Major Businesses
Table 157. Vazyme Biotech Product Models, Descriptions and Specifications
Table 158. Vazyme Biotech Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 159. Vazyme Biotech Recent Developments
Table 160. Key Raw Materials Distribution
Table 161. Raw Materials Key Suppliers
Table 162. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 163. Milestones in Production Technology Evolution
Table 164. Distributors List
Table 165. Market Trends and Market Evolution
Table 166. Market Drivers and Opportunities
Table 167. Market Challenges, Risks, and Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Colloidal Gold Immunochromatography Products Product Picture
Figure 2. Global Colloidal Gold Immunochromatography Products Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Drug and Drug Test Strips & Kits Product Picture
Figure 4. Infectious Disease Test Strips & Kits Product Picture
Figure 5. Cardiac Marker Test Strips & Kits Product Picture
Figure 6. Tumor Marker Detection Test Strips & Kits Product Picture
Figure 7. Others Product Picture
Figure 8. Global Colloidal Gold Immunochromatography Products Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Medical
Figure 10. Domestic
Figure 11. Others
Figure 12. Colloidal Gold Immunochromatography Products Report Years Considered
Figure 13. Global Colloidal Gold Immunochromatography Products Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 15. Global Colloidal Gold Immunochromatography Products Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Colloidal Gold Immunochromatography Products Revenue Market Share by Region (2020-2031)
Figure 17. Global Colloidal Gold Immunochromatography Products Sales (2020-2031) & (M Units)
Figure 18. Global Colloidal Gold Immunochromatography Products Sales (CAGR) by Region (2020-2031) (M Units)
Figure 19. Global Colloidal Gold Immunochromatography Products Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Colloidal Gold Immunochromatography Products Sales Volume Market Share in 2024
Figure 21. Global Colloidal Gold Immunochromatography Products Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. Drug and Drug Test Strips & Kits Revenue Market Share by Manufacturer in 2024
Figure 24. Infectious Disease Test Strips & Kits Revenue Market Share by Manufacturer in 2024
Figure 25. Cardiac Marker Test Strips & Kits Revenue Market Share by Manufacturer in 2024
Figure 26. Tumor Marker Detection Test Strips & Kits Revenue Market Share by Manufacturer in 2024
Figure 27. Others Revenue Market Share by Manufacturer in 2024
Figure 28. Global Colloidal Gold Immunochromatography Products Sales Market Share by Type (2020-2031)
Figure 29. Global Colloidal Gold Immunochromatography Products Revenue Market Share by Type (2020-2031)
Figure 30. Global Colloidal Gold Immunochromatography Products Sales Market Share by Application (2020-2031)
Figure 31. Global Colloidal Gold Immunochromatography Products Revenue Market Share by Application (2020-2031)
Figure 32. North America Colloidal Gold Immunochromatography Products Sales YoY (2020-2031) & (M Units)
Figure 33. North America Colloidal Gold Immunochromatography Products Revenue YoY (2020-2031) & (US$ Million)
Figure 34. North America Top 5 Manufacturers Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) in 2024
Figure 35. North America Colloidal Gold Immunochromatography Products Sales Volume (M Units) by Type (2020- 2031)
Figure 36. North America Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 37. North America Colloidal Gold Immunochromatography Products Sales Volume (M Units) by Application (2020-2031)
Figure 38. North America Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) by Application (2020-2031)
Figure 39. US Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 40. Canada Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 41. Mexico Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 42. Europe Colloidal Gold Immunochromatography Products Sales YoY (2020-2031) & (M Units)
Figure 43. Europe Colloidal Gold Immunochromatography Products Revenue YoY (2020-2031) & (US$ Million)
Figure 44. Europe Top 5 Manufacturers Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) in 2024
Figure 45. Europe Colloidal Gold Immunochromatography Products Sales Volume (M Units) by Type (2020-2031)
Figure 46. Europe Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) by Type (2020-2031)
Figure 47. Europe Colloidal Gold Immunochromatography Products Sales Volume (M Units) by Application (2020-2031)
Figure 48. Europe Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) by Application (2020-2031)
Figure 49. Germany Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 50. France Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 51. U.K. Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 52. Italy Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 53. Russia Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Colloidal Gold Immunochromatography Products Sales YoY (2020-2031) & (M Units)
Figure 55. Asia-Pacific Colloidal Gold Immunochromatography Products Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Asia-Pacific Top 8 Manufacturers Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) in 2024
Figure 57. Asia-Pacific Colloidal Gold Immunochromatography Products Sales Volume (M Units) by Type (2020- 2031)
Figure 58. Asia-Pacific Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 59. Asia-Pacific Colloidal Gold Immunochromatography Products Sales Volume (M Units) by Application (2020-2031)
Figure 60. Asia-Pacific Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) by Application (2020-2031)
Figure 61. Indonesia Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 62. Japan Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 63. South Korea Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 64. China Taiwan Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 65. India Colloidal Gold Immunochromatography Products Revenue (2020-2031) & (US$ Million)
Figure 66. Central and South America Colloidal Gold Immunochromatography Products Sales YoY (2020-2031) & (M Units)
Figure 67. Central and South America Colloidal Gold Immunochromatography Products Revenue YoY (2020-2031) & (US$ Million)
Figure 68. Central and South America Top 5 Manufacturers Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) in 2024
Figure 69. Central and South America Colloidal Gold Immunochromatography Products Sales Volume (M Units) by Type (2021-2031)
Figure 70. Central and South America Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) by Type (2020-2031)
Figure 71. Central and South America Colloidal Gold Immunochromatography Products Sales Volume (M Units) by Application (2020-2031)
Figure 72. Central and South America Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) by Application (2020-2031)
Figure 73. Brazil Colloidal Gold Immunochromatography Products Revenue (2020-2025) & (US$ Million)
Figure 74. Argentina Colloidal Gold Immunochromatography Products Revenue (2020-2025) & (US$ Million)
Figure 75. Middle East, and Africa Colloidal Gold Immunochromatography Products Sales YoY (2020-2031) & (M Units)
Figure 76. Middle East and Africa Colloidal Gold Immunochromatography Products Revenue YoY (2020-2031) & (US$ Million)
Figure 77. Middle East and Africa Top 5 Manufacturers Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) in 2024
Figure 78. Middle East and Africa Colloidal Gold Immunochromatography Products Sales Volume (M Units) by Type (2021-2031)
Figure 79. South America Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) by Type (2020-2031)
Figure 80. Middle East and Africa Colloidal Gold Immunochromatography Products Sales Volume (M Units) by Application (2020-2031)
Figure 81. Middle East and Africa Colloidal Gold Immunochromatography Products Sales Revenue (US$ Million) by Application (2020-2031)
Figure 82. GCC Countries Colloidal Gold Immunochromatography Products Revenue (2020-2025) & (US$ Million)
Figure 83. Turkey Colloidal Gold Immunochromatography Products Revenue (2020-2025) & (US$ Million)
Figure 84. Egypt Colloidal Gold Immunochromatography Products Revenue (2020-2025) & (US$ Million)
Figure 85. South Africa Colloidal Gold Immunochromatography Products Revenue (2020-2025) & (US$ Million)
Figure 86. Colloidal Gold Immunochromatography Products Industry Chain Mapping
Figure 87. Regional Colloidal Gold Immunochromatography Products Manufacturing Base Distribution (%)
Figure 88. Global Colloidal Gold Immunochromatography Products Production Market Share by Region (2020-2031)
Figure 89. Colloidal Gold Immunochromatography Products Production Process
Figure 90. Regional Colloidal Gold Immunochromatography Products Production Cost Structure
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Colloidal Gold Immunochromatography Products in 2031?
The global market size of Colloidal Gold Immunochromatography Products in 2031 was 3058 Million USD.
Which companies rank high in the global Colloidal Gold Immunochromatography Products market?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Colloidal Gold Immunochromatography Products market size from 2025 to 2031?
What was the global market size of Colloidal Gold Immunochromatography Products in 2025?
Related Reports
Global Colloidal Gold Immunochromatography Products Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Colloidal Gold Immunochromatography Products market size was US$ 2501 million in 2025 and is forecast to reach a readjusted size of US$ 3152 million by 2032 with a CAGR of 3.4% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 106
USD 4250.00
(Single User License)
Global Colloidal Gold Immunochromatography Products Market Research Report 2026
The global Colloidal Gold Immunochromatography Products market was valued at US$ 2501 million in 2025 and is anticipated to reach US$ 3152 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 130
USD 2900.00
(Single User License)
Colloidal Gold Immunochromatography Products- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Colloidal Gold Immunochromatography Products was estimated to be worth US$ 2501 million in 2025 and is projected to reach US$ 3152 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 132
USD 3950.00
(Single User License)
Colloidal Gold Immunochromatography Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Colloidal Gold Immunochromatography Products was estimated to be worth US$ 2864 million in 2024 and is forecast to a readjusted size of US$ 3058 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-10-10
Pages: 140
USD 3950.00
(Single User License)
Global Colloidal Gold Immunochromatography Products Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Colloidal Gold Immunochromatography Products market size was US$ 2864 million in 2024 and is forecast to a readjusted size of US$ 3058 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-09-21
Pages: 101
USD 4250.00
(Single User License)
Global Colloidal Gold Immunochromatography Products Market Research Report 2025
The global market for Colloidal Gold Immunochromatography Products was valued at US$ 2864 million in the year 2024 and is projected to reach a revised size of US$ 3058 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published Date: 2025-09-21
Pages: 105
USD 2900.00
(Single User License)
Colloidal Gold Immunochromatography Products- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Colloidal Gold Immunochromatography Products was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 155
USD 3950.00
(Single User License)
Global Colloidal Gold Immunochromatography Products Market Insights, Forecast to 2030
Colloidal gold is gold particles of a certain size that are polymerized into gold ions of a certain size after the reduction of gold ions by chloroauric acid (HAuCl4) under the action of reducing agents such as white phosphorus, ascorbic acid, sodium citrate, and tannic acid. The crystal nucleus (icosahedron formed by 11 gold atoms) and the surrounding double ion layer (the inner layer is the negative ion layer AuCl2-, the outer layer is the positively charged H+). Due to the electrostatic effect, the gold particles repel each other and suspend into a stable colloidal state, forming a negatively charged hydrophobic glue solution, so it is called colloidal gold. Colloidal gold has high electron density and can be combined with a variety of biological macromolecules. It has become a non-radioactive tracer commonly used in immunolabeling technology after fluorescein, radioisotopes and enzymes.
Published Date: 2024-04-28
Pages: 129
USD 4900.00
(Single User License)
Global Colloidal Gold Immunochromatography Products Market Research Report 2024
Colloidal gold is gold particles of a certain size that are polymerized into gold ions of a certain size after the reduction of gold ions by chloroauric acid (HAuCl4) under the action of reducing agents such as white phosphorus, ascorbic acid, sodium citrate, and tannic acid. The crystal nucleus (icosahedron formed by 11 gold atoms) and the surrounding double ion layer (the inner layer is the negative ion layer AuCl2-, the outer layer is the positively charged H+). Due to the electrostatic effect, the gold particles repel each other and suspend into a stable colloidal state, forming a negatively charged hydrophobic glue solution, so it is called colloidal gold. Colloidal gold has high electron density and can be combined with a variety of biological macromolecules. It has become a non-radioactive tracer commonly used in immunolabeling technology after fluorescein, radioisotopes and enzymes.
Published Date: 2024-02-05
Pages: 113
USD 2900.00
(Single User License)
Global Colloidal Gold Immunochromatography Products Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Colloidal Gold Immunochromatography Products market size was US$ 2501 million in 2025 and is forecast to reach a readjusted size of US$ 3152 million by 2032 with a CAGR of 3.4% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 106
USD 4250.00 (Single User License)Global Colloidal Gold Immunochromatography Products Market Research Report 2026
The global Colloidal Gold Immunochromatography Products market was valued at US$ 2501 million in 2025 and is anticipated to reach US$ 3152 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 130
USD 2900.00 (Single User License)Colloidal Gold Immunochromatography Products- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Colloidal Gold Immunochromatography Products was estimated to be worth US$ 2501 million in 2025 and is projected to reach US$ 3152 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 132
USD 3950.00 (Single User License)Colloidal Gold Immunochromatography Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Colloidal Gold Immunochromatography Products was estimated to be worth US$ 2864 million in 2024 and is forecast to a readjusted size of US$ 3058 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-10-10
Pages: 140
USD 3950.00 (Single User License)Global Colloidal Gold Immunochromatography Products Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Colloidal Gold Immunochromatography Products market size was US$ 2864 million in 2024 and is forecast to a readjusted size of US$ 3058 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-09-21
Pages: 101
USD 4250.00 (Single User License)Global Colloidal Gold Immunochromatography Products Market Research Report 2025
The global market for Colloidal Gold Immunochromatography Products was valued at US$ 2864 million in the year 2024 and is projected to reach a revised size of US$ 3058 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published: 2025-09-21
Pages: 105
USD 2900.00 (Single User License)Colloidal Gold Immunochromatography Products- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Colloidal Gold Immunochromatography Products was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 155
USD 3950.00 (Single User License)Global Colloidal Gold Immunochromatography Products Market Insights, Forecast to 2030
Colloidal gold is gold particles of a certain size that are polymerized into gold ions of a certain size after the reduction of gold ions by chloroauric acid (HAuCl4) under the action of reducing agents such as white phosphorus, ascorbic acid, sodium citrate, and tannic acid. The crystal nucleus (icosahedron formed by 11 gold atoms) and the surrounding double ion layer (the inner layer is the negative ion layer AuCl2-, the outer layer is the positively charged H+). Due to the electrostatic effect, the gold particles repel each other and suspend into a stable colloidal state, forming a negatively charged hydrophobic glue solution, so it is called colloidal gold. Colloidal gold has high electron density and can be combined with a variety of biological macromolecules. It has become a non-radioactive tracer commonly used in immunolabeling technology after fluorescein, radioisotopes and enzymes.
Published: 2024-04-28
Pages: 129
USD 4900.00 (Single User License)Global Colloidal Gold Immunochromatography Products Market Research Report 2024
Colloidal gold is gold particles of a certain size that are polymerized into gold ions of a certain size after the reduction of gold ions by chloroauric acid (HAuCl4) under the action of reducing agents such as white phosphorus, ascorbic acid, sodium citrate, and tannic acid. The crystal nucleus (icosahedron formed by 11 gold atoms) and the surrounding double ion layer (the inner layer is the negative ion layer AuCl2-, the outer layer is the positively charged H+). Due to the electrostatic effect, the gold particles repel each other and suspend into a stable colloidal state, forming a negatively charged hydrophobic glue solution, so it is called colloidal gold. Colloidal gold has high electron density and can be combined with a variety of biological macromolecules. It has become a non-radioactive tracer commonly used in immunolabeling technology after fluorescein, radioisotopes and enzymes.
Published: 2024-02-05
Pages: 113
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now